CIK 0001650664 · Non-accelerated filer<br>Smaller reporting company
Editas Medicine, Inc.
Sign in to watch- Ticker
- EDIT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464097528
- Phone
- 617-401-9000
- Business address
- 11 HURLEY ST., CAMBRIDGE, MA, 02141
- 4 Planned sale EVP, CHIEF SCIENTIFIC OFFICER sold 749 shares at $2.02 ($1,513)
- 144 Insider Sale of Securities
- 4 Planned sale EVP, CHIEF SCIENTIFIC OFFICER sold 713 shares at $2.15 ($1,535)
- 4 Planned sale CEO sold 5,603 shares at $2.15 ($12,064)
- 4 Planned sale SVP, Chief Financial Officer sold 461 shares at $2.15 ($993)
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Regulation FD disclosure · Other events
- 4 Planned sale EVP, CHIEF SCIENTIFIC OFFICER sold 710 shares at $2.60 ($1,843)
- 4 Planned sale SVP, Chief Financial Officer sold 458 shares at $2.60 ($1,189)
- 4 Planned sale CEO sold 5,592 shares at $2.60 ($14,517)
- 8-K Event Regulation FD disclosure · Other events
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Planned sale SVP, Chief Financial Officer sold 679 shares at $2.58 ($1,752)
- 4 Planned sale EVP, CHIEF SCIENTIFIC OFFICER sold 5,121 shares at $2.49 ($12,757)
- 144 Insider Sale of Securities
Page 4 of 37 · 731 filings